6Rossi AC, Knapp DE. Discovery of new adverse drug reactions. A review of the Food and Drug Administration's spontaneous reporting system [ J ]. JAMA, 1984,252 ( 8 ) : 1030- 1033.
7Hauben M, Horn S, Reich L. Potential use of data - mining algorithms for the detection of 'surprise' adverse drug reactions[J].Drug Saf, 2007,30(2) : 143-155.
4Guideline on Risk Management Systems for Medicinal Products tor Human USE. Ref. EMEA/CHMP/96268/2005. London. 2005-11-14
5Wolfe SM. Remedies Needed to Address the Pathology in Reporting Adverse Reactions and Food and Drug Administration Use of Reports [ J ]. J Gen Intern Meal,2003,18 ( 1 ) :72-73
6Ahmad SR. Adverse drug event monitoring at the Food and Drug Administration: your report can make a difference [ J ]. J Gen Intern Med,2003,18:56-59
7Rossi AC, Knapp DE. Discovery of new adverse drug reactions. A review of the Food and Drug Administrationg spontaneous reporting system [J].JAMA, 1984,252 ( 8 ) : 1030-1033
8Hartnell NR, Wilson JP. Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration [ J ]. Pharmacotherapy, 2004,24 ( 6 ) : 743-749
9Hauben M, Horn S, Reich L. Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions [ J ]. Drug Saf,2007,30(2) : 143-155
